Swaransh Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Jammu, Jammu & Kashmir, India, established in 2024.
2024 Jammu, Jammu & Kashmir, India Active
Last Updated:
Access Report
About Swaransh Pharmaceuticals Private Limited

Swaransh Pharmaceuticals Private Limited, a active private limited company, was established on 21 May 2024 in Jammu, Jammu & Kashmir, India. it holds CIN: U46497JK2024PTC016068. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Raj Kumar Dogra (Director), Pinky Kumari Dogra (Director). It holds ₹4.00 M open charges and no settled loans. It is based at H No-37/C, New Plot, Jammu, Jammu & Kashmir, 180005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497JK2024PTC016068

  • Registration Number

    016068

  • Incorporation Date

    21 May 2024

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jammu

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 9 Months
  • Open Charges ₹ 4.00 M
Company report

Swaransh Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Swaransh Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Swaransh Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Raj Kumar Dogra Director 21 May 2024 Current
Pinky Kumari Dogra Director 21 May 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Swaransh Pharmaceuticals.

Enhance accessibility to Swaransh Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Swaransh Pharmaceuticals revenue growth over time
Swaransh Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Swaransh Pharmaceuticals?

Unlock access to Swaransh Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2025 Hdfc Bank Limited ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Swaransh Pharmaceuticals?

Unlock and access historical data on people associated with Swaransh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Swaransh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaransh Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Swaransh Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 4.00 M with Charge ID 101149583 was registered on 13 Aug 2025. was recorded as a recent event.

  • Director Appointment

    Raj Kumar Dogra was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Pinky Kumari Dogra was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Company Incorporation

    Progress on Swaransh Pharmaceuticals Private Limited was registered on 21 May 2024 with Roc Jammu & aged 1 year 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Swaransh Pharmaceuticals Private Limited?

The CIN of Swaransh Pharmaceuticals Private Limited is U46497JK2024PTC016068.

Where is Swaransh Pharmaceuticals Private Limited headquartered?

Swaransh Pharmaceuticals Private Limited is headquartered at H No-37/C, New Plot, Jammu, Jammu & Kashmir, 180005.

When was Swaransh Pharmaceuticals Private Limited incorporated?

Swaransh Pharmaceuticals Private Limited was incorporated on 21 May 2024.

Who are the current directors of Swaransh Pharmaceuticals Private Limited?

The current directors of Swaransh Pharmaceuticals Private Limited are

Is Swaransh Pharmaceuticals Private Limited a listed company?

Swaransh Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Swaransh Pharmaceuticals Private Limited?

The authorized capital of Swaransh Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available